Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
2025 · 4th Quarter (Oct 1 - Dec 31)
MADRIGAL PHARMACEUTICALS, INC.
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CROSSROADS STRATEGIES, LLC
- Filing UUID
- 3e77bea9-d15f-4ff8-9868-8ec7b55e2fee
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to CMMI Drug Pricing Demonstration Programs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.